An open-label extension study to CQTI571A2102 to evaluate the long-term safety, tolerability and efficacy of QTI571 (imatinib) in the treatment of severe pulmonary arterial hypertension

To evaluate the long-term safety and tolerability of QTI571 in patients with severe pulmonary arterial hypertension.